In vivo monitoring of mGluR1 by PET using [11C]ITMM with ultra-high SA can further our understanding of unknown mechanisms of mGluR1, and may help in the development of new medications for CNS disorders, such as schizophrenia. Here, GRM1 is linked to central nervous system disorder.